Navigation Links
Prize-winning research on solubility by Hebrew University doctoral student yields promise
Date:12/15/2011

Jerusalem --A method for increasing solubility (the ability of one substance to dissolve into another), developed by a graduate student at the Hebrew University of Jerusalem Casali Institute of Applied Chemistry, has yielded promising commercial benefits for industry, particularly in pharmaceuticals, cosmetics and agriculture.

The method, developed by Katy Margulis-Goshen, a Ph.D. student of Prof. Shlomo Magdassi, produces a rapid conversion of oil-in-water microemulsions, containing an insoluble substance, into a dry powder composed of nanoparticles which can easily be dissolved in water or other biological fluids.

For her work, Marguis-Goshen, who immigrated to Israel from the Ukraine in 1990, was chosen as one of the winners of this year's Kaye Innovation Awards at the university.

The process she developed is of unique industrial importance, since it leads to a significant increase in solubility and dissolution properties of almost any active ingredient, without a high energy investment.

Enhancing such solubility is especially important in the field of pharmaceutics, where nearly 50% of the newly discovered drugs cannot be administered or are very poorly absorbed due to their low solubility. Increasing solubility is also important in the field of agriculture, since the majority of insecticides are highly hydrophobic (resistant to mixing with water), and their regular application therefore requires the use of organic solvents, which are harmful to the farmer and the environment.

In cosmetics, active cosmetic ingredients for dermal delivery are usually also water resistant, so that incorporating them into non-greasy, water-based formulations is of great importance. The new process invented by Margulis-Goshen can be also applied in many other fields, such as nutrition and the manufacture of printing ink and paint.

If the active ingredient, for example, is a water-resistant drug, the powder developed in her method may be injec
'/>"/>

Contact: Jerry Barach
jerryb@savion.huji.ac.il
972-258-82904
The Hebrew University of Jerusalem
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Researchers explain what makes granular material become solid
2. London researchers lead innovative new cancer treatment study
3. Antioxidant has potential in the Alzheimers fight, UGA researchers find
4. Important international collaboration with University of Guam researcher
5. Stand Up to Cancer and Melanoma Research Alliance announce dream team
6. Rose torture: severe heat in Texas yields better varieties for research
7. Intestine crucial to function of immune cells, research shows
8. UC Davis researcher develops model to foster new drug development to treat pain and epilepsy
9. Lawson research team working to personalize cancer care
10. Control by the matrix: RUB researchers decipher the role of proteins in the cell environment
11. UH Seidman Cancer Center researchers present at American Society of Hematology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Prize-winning research on solubility by Hebrew University doctoral student yields promise
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, ... the start of a new Phase III double blind, ... its novel formulation, CM-AT, on all children ages 3-8 ... its FDA Phase III double blinded clinical trial for ... low levels of the digestive enzyme chymotrypsin. This new ...
(Date:5/5/2015)... 2015, NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... growing mobile commerce market, reminds investors and media that  Mr. ... presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, held in ... The three-day conference is organized into a series of ... themed Global Fraud: Where is the Trust in Cyberspace? ...
(Date:4/20/2015)... , April 20, 2015 Huntington Memorial ... Valley to implant a new miniaturized, wireless monitoring sensor ... is the first and only FDA-approved heart failure monitoring ... admissions when used by physicians to manage heart failure. ... that is implanted in the pulmonary artery (PA) during ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3
... University provides molecular-level insights into how cellulose the ... structural component of plant cell walls breaks down ... into any number of useful products, including liquid transportation ... Using a supercomputer that can perform functions thousands of ...
... Ridge, Ill. (December 14, 2012) It is estimated ... prevalent condition known as metabolic syndrome which is a ... factors: large waistline, high triglycerides, low HDL cholesterol, high ... a variety of risk factors that increase the likelihood ...
... 13, 2012 Swift Charities, the charitable arm of ... Fund for Diabetes Research at the Translational Genomics Research ... The Waylon Fund was Swift,s "charity of choice." ... as well as matching contributions from Phoenix-based Swift, were ...
Cached Biology News:Study fuels insight into conversion of wood to bio-oil 2Use 'em, don't lose 'em! Eating egg yolks adds nutritious benefits 2Use 'em, don't lose 'em! Eating egg yolks adds nutritious benefits 3Swift Transportation donates more than $15,000 to the Waylon Fund 2
(Date:6/2/2015)... , June 2, 2015 GOJO, inventors ... its commitment to antibiotic stewardship at the White House ... and animal health organizations and stakeholders at the White ... years to slow the emergence of antibiotic-resistant bacteria, detect ... and prevent the spread of resistant infections. ...
(Date:6/2/2015)... CA (PRWEB) June 02, 2015 German-based ... official United States distributor for the Moenninghoff product ... stated, “I am pleased to announce that the R.M. ... market. For our firm, founded in 1916, this is ... R.M. Hoffman is the kind of professional distributor we ...
(Date:6/1/2015)...  Turing Pharmaceuticals AG announced that life sciences executive ... MSc,  has joined the company as president of ... holds a medical degree as well as a ... accomplishments in the pharmaceutical industry, and extensive clinical ... played a leadership role in numerous programs for ...
(Date:6/1/2015)... CHICAGO and RARITAN, N.J. ... & Development, LLC (Janssen) announced data from the ... significant improvement in progression-free survival (PFS) with trabectedin ... with advanced liposarcoma (LPS) or leiomyosarcoma (LMS) previously ... additional chemotherapy regimen. SAR3007 is the largest randomized ...
Breaking Biology Technology:GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 2GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 3GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 4R.M. Hoffman Company designated official United States distributor for the Moenninghoff product line. 2R.M. Hoffman Company designated official United States distributor for the Moenninghoff product line. 3Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 2Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 3Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 2Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 3Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 4Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 5Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 6
... Simple Steps Can Make a Big Difference in Managing ... As this year,s spring nasal allergy season quickly ... to manage their symptoms and ward-off allergens before they ... nasal allergy sufferers prepare for the spring nasal allergy ...
... 2 Epistem Plc,(LSE:EHP) the UK biotechnology and ... a research and development collaboration with Novartis,to identify ... of disease,areas. , The ... programme, with Novartis,s insights into disease pathways &,bioinformatics. ...
... 2 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group,(NYSE: ... branded generic,pharmaceuticals and innovative anti-cancer pharmaceuticals in the ... to release its 2008,fourth quarter and full year ... opens in the United States. Simcere,s chief executive ...
Cached Biology Technology:Video: Experts Unite to Help People Manage Spring Nasal Allergy Sneezin' 2Video: Experts Unite to Help People Manage Spring Nasal Allergy Sneezin' 3Video: Experts Unite to Help People Manage Spring Nasal Allergy Sneezin' 4Video: Experts Unite to Help People Manage Spring Nasal Allergy Sneezin' 5Video: Experts Unite to Help People Manage Spring Nasal Allergy Sneezin' 6Epistem Announces Research and Development Collaboration With a Major Pharmaceutical Company 2Simcere Pharmaceutical Group to Announce 2008 Fourth Quarter and Full Year Earnings On Thursday, March 12, 2009 2
... Express Cloning Checker Kits provide two highly ... transformation without time-consuming plasmid preparation. By using ... all you need to do is to ... directly from the transformation plates into the ...
Recombinant Equine IL-4, CF...
DALT GRADIENT MAKER,230V, 1 EA. Category: 2D DALT Systems....
delta-like 1 homolog (Drosophila)...
Biology Products: